Haig Aghajanian

Haig Aghajanian is Co-Founder and Vice President of Research at Capstan Therapeutics, as well as Adjunct Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania. His research has focused on the etiology of cardiac disease and cell therapy for the treatment of fibrosis culminating in his recent work published in Nature and Science that served as the inception of Capstan.